Purple Biotech (XTAE:PPBT) Additional Paid-In Capital : ₪509.82 Mil(As of Dec. 2023)

View and export this data going back to 1978. Start your Free Trial

What is Purple Biotech Additional Paid-In Capital?

Purple Biotech's quarterly additional paid-in capital increased from Jun. 2023 (₪506.22 Mil) to Sep. 2023 (₪509.20 Mil) and increased from Sep. 2023 (₪509.20 Mil) to Dec. 2023 (₪509.82 Mil).

Purple Biotech's annual additional paid-in capital increased from Dec. 2021 (₪474.47 Mil) to Dec. 2022 (₪483.87 Mil) and increased from Dec. 2022 (₪483.87 Mil) to Dec. 2023 (₪509.82 Mil).

Purple Biotech Additional Paid-In Capital Historical Data

The historical data trend for Purple Biotech's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Purple Biotech Additional Paid-In Capital Chart

Purple Biotech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

179.86

455.17

474.47

483.87

509.82

Purple Biotech Quarterly Data
	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Additional Paid-In Capital	Get a 7-Day Free Trial															483.87	500.39	506.22	509.20	509.82

Purple Biotech Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Purple Biotech Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Purple Biotech's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Purple Biotech (XTAE:PPBT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Purple Biotech Ltd (XTAE:PPBT) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

PPBT:USA 1YI1:Germany

Address

4 Oppenheimer Street, Science Park, Rehovot, ISR, 7670104

Website

https://www.purple-biotech.com

Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.